Rush University Medical Center is offering a newly FDA-approved treatment for brain aneurysms that is safer for patients and has a shorter recovery period than other treatments.
Neurology and Neurosurgery
Dramatic changes in barometric pressure may increase the incidence of a type of stroke known as spontaneous intracerebral hemorrhage, a study found.
A lab study led by a Rush researcher has found that a treatment cleared brain cells of a protein that is an integral cause of Parkinson's disease.
Levels of a protein found in the brain called alpha-synuclein are significantly lower than normal in cerebrospinal fluid collected in Parkinson’s disease patients suffering from postural instability and gait difficulty, a study has found.
Four of six people with paralyzing spinal cord injuries who were treated with a new cell therapy have recovered a significant level of movement on at least one side, new study results show.
Rush has launched a telemedicine program for movement disorders patients, the latest example of Rush using technology to improve access to care.
A new drug that is the first and only disease modifying therapy for both primary progressive and relapsing forms of multiple sclerosis (MS) is giving new hope for hundreds of thousands of Americans living with the disease.
Mechanical thrombectomy, a treatment to remove a stroke-causing blood clot in the brain, is effective in some patients even when performed within six to 24 hours after a stroke, according to the results of an international research study.
Two genes are associated with people having better cognitive function than expected, given the damage in their brains due to conditions of aging.
A new elective rotation for neurology residents will bring badly needed care to Zambia while teaching lessons doctors will bring back to the U.S.